NPPB and pulmonary arterial hypertension: This review provides support for 6MWD, FC, and BNP/NT-proBNP as correlates of risk of long-term health outcomes (e.g., mortality and clinical worsening), costly events (e.g., lung transplants or hospitalization), and economic outcomes (e.g., costs and resource utilization) in PAH.